Prognostic, clinicopathological, and immune correlation of NLRP3 promoter methylation in kidney renal clear cell carcinoma

Clin Transl Med. 2021 Oct;11(10):e528. doi: 10.1002/ctm2.528.

Authors

Qian Long¹, Liru He¹, Jin Peng¹, Qi Meng¹, Changlin Zhang², Miao Chen¹, Xiaonan Wang¹, Wancui Zhu¹, Fufu Zheng³, Pei Dong¹, Wuguo Deng¹

Affiliations

¹ State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
² Department of Gynecology, The Seventh Affiliated Hospital of Sun Yat-sen University, Shenzhen, China.
³ The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Carcinoma, Renal Cell / genetics
Carcinoma, Renal Cell / immunology*
Carcinoma, Renal Cell / pathology*
Humans
Kidney / immunology
Kidney / pathology
Kidney Neoplasms / genetics
Kidney Neoplasms / immunology*
Kidney Neoplasms / pathology*
Methylation
NLR Family, Pyrin Domain-Containing 3 Protein / genetics*
NLR Family, Pyrin Domain-Containing 3 Protein / immunology
NLR Family, Pyrin Domain-Containing 3 Protein / metabolism
Promoter Regions, Genetic / genetics*
Promoter Regions, Genetic / immunology

Substances

NLR Family, Pyrin Domain-Containing 3 Protein
NLRP3 protein, human